| Period Ending | Jan 30, 2013 | Oct 30, 2012 | Jul 30, 2012 | Apr 29, 2012 |
|---|
|
Total Revenue
|
16,210
|
16,384
|
16,811
|
16,568
| | Cost of Revenue | 8,701 | 9,362 | 9,234 | 9,225 | | |
Gross Profit
|
7,510
|
7,022
|
7,577
|
7,343
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
| 1,700 |
|
Selling General and Administrative | 5,964 | 6,494 | 6,279 | 13,018 |
|
Non Recurring | 65 | 298 | 39 | (2,142) |
|
Others | 551 | 539 | 539 | 628 |
|
|
|
Total Operating Expenses |
-
|
-
|
-
| 13,204 | | | |
Operating Income or Loss
|
930
|
(309)
|
721
|
(5,861)
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | (2) | (87) | (78) | (64) |
|
Earnings Before Interest And Taxes | 928 | (396) | 643 | (5,925) |
|
Interest Expense | 371 | 393 | 386 | 401 |
|
Income Before Tax | 557 | (789) | 257 | (6,326) |
|
Income Tax Expense | 369 | (108) | 89 | (1,970) |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 188 | (681) | 168 | (4,356) | |
|
Non-recurring Events |
|
Discontinued Operations | 47 | (138) | (0) | (973) |
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
235
|
(819)
|
168
|
(5,328)
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
235
|
(819)
|
168
|
(5,328)
|
|
0.01(0.92%) 2:20PM EDT - Nasdaq Real Time Price